awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34781067-2F0F1436-401D-4CE0-A36A-7A3EA2C844B8
Q34781067-2F0F1436-401D-4CE0-A36A-7A3EA2C844B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34781067-2F0F1436-401D-4CE0-A36A-7A3EA2C844B8
Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor-positive metastatic breast cancer: a randomized phase II study.
P2860
Q34781067-2F0F1436-401D-4CE0-A36A-7A3EA2C844B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34781067-2F0F1436-401D-4CE0-A36A-7A3EA2C844B8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f0cc5f596c18498da61c5a1886868ad354d6fe84
P2860
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.